Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	183.89	527.42	185.78
Graham Fair Price	281.53	18.69	4.90
PEG	-99.65	-0.06	17.51
Price/Book	25.93	-6.83	-9.22
Price/Cash Flow	-45.11	-29.56	53.86
Prices/Earnings	95.10	-84.65	-1726.87
Price/Sales	-2.85	7.01	7.22
Price/FCF	-45.11	-29.56	53.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.22	0.11	0.12
Operating Margin	-32.38	< 0.005	0.01
ROA	-1419.34	< 0.005	< 0.005
ROE	< 0.005	0.02	1410.94
ROIC	0.03	< 0.005	-83.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	< 0.005	1299.90
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.35	-1.51	11.74
EPS QOQ	0.99	-13.85	1305.10
FCF QOQ	10.52	-2.33	-77.83
Revenue QOQ	0.22	-0.25	14.47
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	371.45	511.53	37.71
Days Sales Outstanding (DSO)	45.23	68.92	52.39
Inventory Turnover	0.24	0.18	-27.39
Debt/Capitalization	1.49	1.55	4.21
Quick Ratio	0.28	0.22	-23.14
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-28.27	-27.75	1.85
Cash	26.19	12.28	-53.10
Capex	-0.71	-0.93	-30.82
Free Cash Flow	4.84	-6.41	32.45
Revenue	36.12	27.03	-25.17
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.14	1.14	0.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	37.30	137.67	269.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating